In Vitro Activity of Cefazolin against Recent Clinical Bacterial Isolates

The in vitro antibacterial activity of cefazolin was determined, by an agar-dilution technique, against 546 recent isolates of bacteria recovered from patients at Boston City Hospital. The activity of cefazolin was comparable to that. of cephalothin against most gram-positive cocci, but the former w...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of infectious diseases Vol. 128; no. Supplement-2; pp. S320 - S326
Main Authors Sabath, L. D., Wilcox, Clare, Garner, Carol, Finland, Maxwell
Format Journal Article
LanguageEnglish
Published United States The University of Chicago Press 01.10.1973
University of Chicago Press
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The in vitro antibacterial activity of cefazolin was determined, by an agar-dilution technique, against 546 recent isolates of bacteria recovered from patients at Boston City Hospital. The activity of cefazolin was comparable to that. of cephalothin against most gram-positive cocci, but the former was more active against most strains of Escherichia coli and Klebsiella and against some isolates of Enterobacter. Neither of these two cephalosporins had significant activity against Serratia or Pseudomonas. The median MICs of undiluted cultures of some gramnegative bacilli tested in agar were 32–85 times higher than those of the same cultures diluted 1: 1,000 before inoculation. The results of these tests of susceptibility were influenced by the composition of the medium, sometimes by a factor of 16; none of the four media gave consistently higher or lower values with strains of all species tested.
Bibliography:This work was aided, in part, by grants no. 5R01-AI-23 and 2T01-AI-68 from the National Institute of Allergy and Infectious Diseases.
istex:A0E6586B75388C4399B96225ED1EC76DB90D9D8E
ark:/67375/HXZ-0T44DSV9-L
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0022-1899
1537-6613
DOI:10.1093/infdis/128.Supplement_2.S320